Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

10-Year Survival of Patients with AIDS Receiving Antiretroviral Therapy in Haiti.

Pierre S, Jannat-Khah D, Fitzgerald DW, Pape J, McNairy ML.

N Engl J Med. 2016 Jan 28;374(4):397-8. doi: 10.1056/NEJMc1508934. No abstract available.

2.

A Second Look at the Association between Gender and Mortality on Antiretroviral Therapy.

Koenig SP, Bornstein A, Severe K, Fox E, Dévieux JG, Severe P, Joseph P, Marcelin A, Bright DA, Pham N, Cremieux P, Pape JW.

PLoS One. 2015 Nov 12;10(11):e0142101. doi: 10.1371/journal.pone.0142101. eCollection 2015.

3.

Incidence and predictors of adverse drug events in an African cohort of HIV-infected adults treated with efavirenz.

Abah IO, Akanbi M, Abah ME, Finangwai AI, Dady CW, Falang KD, Ebonyi AO, Okopi JA, Agbaji OO, Sagay AS, Okonkwo P, Idoko JA, Kanki PJ.

Germs. 2015 Sep 1;5(3):83-91. doi: 10.11599/germs.2015.1075. eCollection 2015 Sep.

4.

Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.

Carriquiry G, Fink V, Koethe JR, Giganti MJ, Jayathilake K, Blevins M, Cahn P, Grinsztejn B, Wolff M, Pape JW, Padgett D, Madero JS, Gotuzzo E, McGowan CC, Shepherd BE.

J Int AIDS Soc. 2015 Jul 10;18:20016. doi: 10.7448/IAS.18.1.20016. eCollection 2015.

5.

Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature.

Tang AM, Quick T, Chung M, Wanke CA.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S340-9. doi: 10.1097/QAI.0000000000000521. Review.

6.

Evaluation of adverse drug reactions in HIV positive patients in a tertiary care hospital.

Jha AK, Gadgade A, Shenoy AK, Chowta MN, Ramapuram JT.

Perspect Clin Res. 2015 Jan-Mar;6(1):34-8. doi: 10.4103/2229-3485.148808.

7.

Patient attrition from the HIV antiretroviral therapy program at two hospitals in Haiti.

Puttkammer NH, Zeliadt SB, Baseman JG, Destiné R, Wysler Domerçant J, Labbé Coq NR, Atwood Raphael N, Sherr K, Tegger M, Yuhas K, Barnhart S.

Rev Panam Salud Publica. 2014 Oct;36(4):238-47.

8.

Inpatient mortality of HIV-infected adults in sub-Saharan Africa and possible interventions: a mixed methods review.

Wajanga BM, Webster LE, Peck RN, Downs JA, Mate K, Smart LR, Fitzgerald DW.

BMC Health Serv Res. 2014 Dec 3;14:627. doi: 10.1186/s12913-014-0627-9. Review.

9.

Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.

Sarfo FS, Sarfo MA, Norman B, Phillips R, Bedu-Addo G, Chadwick D.

PLoS One. 2014 Oct 23;9(10):e111400. doi: 10.1371/journal.pone.0111400. eCollection 2014.

10.

Performance of a mathematical model to forecast lives saved from HIV treatment expansion in resource-limited settings.

Kimmel AD, Fitzgerald DW, Pape JW, Schackman BR.

Med Decis Making. 2015 Feb;35(2):230-42. doi: 10.1177/0272989X14551755. Epub 2014 Oct 20.

11.

Evaluating the utility of early laboratory monitoring of antiretroviral-induced haematological and hepatic toxicity in HIV-infected persons in Cameroon.

Bekolo CE, Sonkoue C, Djidjou H, Bekoule PS, Kollo B.

BMC Infect Dis. 2014 Sep 25;14:519. doi: 10.1186/1471-2334-14-519.

12.

Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.

Riviere C, Faust E, Miller T, Beck EJ, Baruwa E, Severe P, Severe K, Riché CT, Cassagnol R, Atwood S, Esperance M, Webster L, Cremieux P, Pape JW, Koenig SP.

J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):e72-9. doi: 10.1097/QAI.0000000000000200.

13.

Cost-Effectiveness of Improving Health Care to People with HIV in Nicaragua.

Broughton E, Nunez D, Moreno I.

Nurs Res Pract. 2014;2014:232046. doi: 10.1155/2014/232046. Epub 2014 May 25.

14.

Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review.

Link-Gelles R, Moultrie H, Sawry S, Murdoch D, Van Rie A.

Pediatr Infect Dis J. 2014 May;33(5):499-503. doi: 10.1097/INF.0000000000000142. Review.

15.

Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India.

Shet A, Antony J, Arumugam K, Kumar Dodderi S, Rodrigues R, DeCosta A.

PLoS One. 2014 Mar 10;9(3):e91028. doi: 10.1371/journal.pone.0091028. eCollection 2014.

16.

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans.

Nanzigu S, Kiguba R, Kabanda J, Mukonzo JK, Waako P, Kityo C, Makumbi F.

HIV AIDS (Auckl). 2013 Dec 6;5:309-19. doi: 10.2147/HIV.S50614. eCollection 2013.

17.

The Haiti research-based model of international public health collaboration: the GHESKIO Centers.

Pape JW, Severe PD, Fitzgerald DW, Deschamps MM, Joseph P, Riviere C, Rouzier V, Johnson WD Jr.

J Acquir Immune Defic Syndr. 2014 Jan 1;65 Suppl 1:S5-9. doi: 10.1097/QAI.0000000000000031.

18.

Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China.

Xiao J, Gao G, Li Y, Zhang W, Tian Y, Huang Y, Su W, Han N, Yang D, Zhao H.

PLoS One. 2013 Oct 25;8(10):e75915. doi: 10.1371/journal.pone.0075915. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/bbbcd86d-200e-49d6-a3e3-aef3e083fab2. Huang, Yinxiu [corrected to Huang, Yingxiu].

19.

HIV testing of tuberculosis patients by public and private providers in New York City.

Klein PW, Harris TG, Leone PA, Pettifor AE.

J Community Health. 2014 Jun;39(3):494-502. doi: 10.1007/s10900-013-9783-9.

20.

Adverse drug reactions to antiretroviral therapy: Results from spontaneous reporting system in Nigeria.

Agu KA, Oparah AC.

Perspect Clin Res. 2013 Apr;4(2):117-24. doi: 10.4103/2229-3485.111784.

Items per page

Supplemental Content

Write to the Help Desk